Chemomab Therapeutics CMMB
NASDAQ CMMB
$2.16 +0.09 (+4.35%)
At close: Aug 21, 2026 · 4:00 PM EDT

Chemomab Therapeutics (CMMB) Property, Plant & Equipment (Net) (2017 - 2025)

Chemomab Therapeutics (CMMB) Property, Plant & Equipment (Net) (2017 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 2.06 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.64 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 554.14 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 6.80 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 107.22 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Chemomab Therapeutics 13.62 Mn 3.25 Mn - 176,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 176,000.00
Dec 31, 2025 176,000.00
Sep 30, 2025 188,000.00
Sep 30, 2025 188,000.00
Jun 30, 2025 217,000.00
Jun 30, 2025 217,000.00
Mar 31, 2025 237,000.00
Mar 31, 2025 237,000.00
Dec 31, 2024 250,000.00
Dec 31, 2024 250,000.00
Sep 30, 2024 262,000.00
Sep 30, 2024 262,000.00
Jun 30, 2024 276,000.00
Jun 30, 2024 276,000.00
Mar 31, 2024 289,000.00
Mar 31, 2024 289,000.00
Dec 31, 2023 303,000.00
Dec 31, 2023 303,000.00
Sep 30, 2023 319,000.00
Sep 30, 2023 319,000.00